BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 20301198)

  • 1. Protein-protein interactions involving IKKgamma (NEMO) that promote the activation of NF-kappaB.
    Shifera AS
    J Cell Physiol; 2010 Jun; 223(3):558-61. PubMed ID: 20301198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteins that bind to IKKgamma (NEMO) and down-regulate the activation of NF-kappaB.
    Shifera AS
    Biochem Biophys Res Commun; 2010 Jun; 396(3):585-9. PubMed ID: 20457134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF-kappaB activation: Nondegradative ubiquitination implicates NEMO.
    Israël A
    Trends Immunol; 2006 Sep; 27(9):395-7. PubMed ID: 16857427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation and function of IKK and IKK-related kinases.
    Häcker H; Karin M
    Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of NEMO, the regulatory subunit of the IKK complex, induces apoptosis in high-risk myelodysplastic syndrome and acute myeloid leukemia.
    Carvalho G; Fabre C; Braun T; Grosjean J; Ades L; Agou F; Tasdemir E; Boehrer S; Israel A; Véron M; Fenaux P; Kroemer G
    Oncogene; 2007 Apr; 26(16):2299-307. PubMed ID: 17043643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posttranslational modifications of NEMO and its partners in NF-kappaB signaling.
    Sebban H; Yamaoka S; Courtois G
    Trends Cell Biol; 2006 Nov; 16(11):569-77. PubMed ID: 16987664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of a NEMO/IKK-associating domain reveals architecture of the interaction site.
    Rushe M; Silvian L; Bixler S; Chen LL; Cheung A; Bowes S; Cuervo H; Berkowitz S; Zheng T; Guckian K; Pellegrini M; Lugovskoy A
    Structure; 2008 May; 16(5):798-808. PubMed ID: 18462684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The NF-kappa B activation pathway: a paradigm in information transfer from membrane to nucleus.
    Rothwarf DM; Karin M
    Sci STKE; 1999 Oct; 1999(5):RE1. PubMed ID: 11865184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Annexin-1 interacts with NEMO and RIP1 to constitutively activate IKK complex and NF-κB: implication in breast cancer metastasis.
    Bist P; Leow SC; Phua QH; Shu S; Zhuang Q; Loh WT; Nguyen TH; Zhou JB; Hooi SC; Lim LH
    Oncogene; 2011 Jul; 30(28):3174-85. PubMed ID: 21383699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the NF-kappaB survival pathway via caspase-dependent cleavage of the IKK complex scaffold protein and NF-kappaB essential modulator NEMO.
    Frelin C; Imbert V; Bottero V; Gonthier N; Samraj AK; Schulze-Osthoff K; Auberger P; Courtois G; Peyron JF
    Cell Death Differ; 2008 Jan; 15(1):152-60. PubMed ID: 17932497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic protein complexes regulate NF-kappaB signaling.
    Wegener E; Krappmann D
    Handb Exp Pharmacol; 2008; (186):237-59. PubMed ID: 18491055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNFalpha- and IKKbeta-mediated TANK/I-TRAF phosphorylation: implications for interaction with NEMO/IKKgamma and NF-kappaB activation.
    Bonif M; Meuwis MA; Close P; Benoit V; Heyninck K; Chapelle JP; Bours V; Merville MP; Piette J; Beyaert R; Chariot A
    Biochem J; 2006 Mar; 394(Pt 3):593-603. PubMed ID: 16336209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IkappaB kinase complexes: gateways to NF-kappaB activation and transcription.
    Scheidereit C
    Oncogene; 2006 Oct; 25(51):6685-705. PubMed ID: 17072322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The zinc finger domain of IKKγ (NEMO) protein in health and disease.
    Shifera AS
    J Cell Mol Med; 2010 Oct; 14(10):2404-14. PubMed ID: 20345847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct inhibition of NF-κB activation by peptide targeting the NOA ubiquitin binding domain of NEMO.
    Chiaravalli J; Fontan E; Fsihi H; Coic YM; Baleux F; Véron M; Agou F
    Biochem Pharmacol; 2011 Nov; 82(9):1163-74. PubMed ID: 21803029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of NF-kappaB activation with designed ankyrin-repeat proteins targeting the ubiquitin-binding/oligomerization domain of NEMO.
    Wyler E; Kaminska M; Coïc YM; Baleux F; Véron M; Agou F
    Protein Sci; 2007 Sep; 16(9):2013-22. PubMed ID: 17766391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway.
    Perkins ND
    Oncogene; 2006 Oct; 25(51):6717-30. PubMed ID: 17072324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABIN-1 binds to NEMO/IKKgamma and co-operates with A20 in inhibiting NF-kappaB.
    Mauro C; Pacifico F; Lavorgna A; Mellone S; Iannetti A; Acquaviva R; Formisano S; Vito P; Leonardi A
    J Biol Chem; 2006 Jul; 281(27):18482-8. PubMed ID: 16684768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NEMO binding domain of IKK-2 encompasses amino acids 735-745.
    Strnad J; McDonnell PA; Riexinger DJ; Mapelli C; Cheng L; Gray H; Ryseck RP; Burke JR
    J Mol Recognit; 2006; 19(3):227-33. PubMed ID: 16583354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extending the nuclear roles of IkappaB kinase subunits.
    Gloire G; Dejardin E; Piette J
    Biochem Pharmacol; 2006 Oct; 72(9):1081-9. PubMed ID: 16846590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.